rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-29
|
pubmed:abstractText |
The aim of this study was to report the development or progression of tractional retinal detachment (TRD) after the injection of intravitreal bevacizumab (Avastin) used as an adjuvant to vitrectomy for the management of severe proliferative diabetic retinopathy (PDR).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1468-2079
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
213-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17965108-Adult,
pubmed-meshheading:17965108-Angiogenesis Inhibitors,
pubmed-meshheading:17965108-Antibodies, Monoclonal,
pubmed-meshheading:17965108-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:17965108-Chemotherapy, Adjuvant,
pubmed-meshheading:17965108-Diabetes Mellitus, Type 1,
pubmed-meshheading:17965108-Diabetes Mellitus, Type 2,
pubmed-meshheading:17965108-Diabetic Retinopathy,
pubmed-meshheading:17965108-Disease Progression,
pubmed-meshheading:17965108-Female,
pubmed-meshheading:17965108-Humans,
pubmed-meshheading:17965108-Injections,
pubmed-meshheading:17965108-Male,
pubmed-meshheading:17965108-Middle Aged,
pubmed-meshheading:17965108-Retinal Detachment,
pubmed-meshheading:17965108-Retrospective Studies,
pubmed-meshheading:17965108-Vascular Endothelial Growth Factor A,
pubmed-meshheading:17965108-Vitrectomy,
pubmed-meshheading:17965108-Vitreous Body
|
pubmed:year |
2008
|
pubmed:articleTitle |
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
|
pubmed:affiliation |
Clinica Oftalmológica Centro Caracas, Edif. Centro Caracas PH-1, Av. Panteon, San Bernardino, Caracas 1010, Venezuela. arevalojf2020@gmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|